An Artificial Intelligence Tool to Improve Pancreatic Cancer Outcomes

Only 9% of people with pancreatic cancer live for five years after diagnosis. "That is an abysmally low number, probably the worst in human cancers," says Michael Wallace, M.D., a digestive disease specialist at the Mayo Clinic campus in Florida. "We want to get that rate substantially higher." Artificial intelligence is providing a way to do just that. In collaboration with the University of Central Florida (UCF), Mayo Clinic has developed an algorithm that can identify individuals at high risk of pancreatic cancer.